MAIA Biotechnology Investor Presentation Deck
November 2023, 39 slides
  1. MAIA Biotechnology
  2. Related Decks
  3. Investor Presentation Decks
targeting for cancer wean | MAIA Biotechnology
free writing prospectus | MAIA Biotechnology
forward looking statements | MAIA Biotechnology
investment overview | MAIA Biotechnology
robust pipeline | MAIA Biotechnology
science overview thio thio next generation | MAIA Biotechnology
mission and approach | MAIA Biotechnology
million population aged expected to triple by age related a a at age will be diagnosed will die of it | MAIA Biotechnology
thio is the only direct targeting agent currently in clinical development | MAIA Biotechnology
thio mechanisms of action thio targeting sec immunogenic effect | MAIA Biotechnology
agreement announces clinical supply with for phase clinical trial evaluating thio in sequential administration with in advanced non small cell lung cancer | MAIA Biotechnology
thio rationale been induced no cancer cells with no due to thio rechallenge with no additional treatment | MAIA Biotechnology
thio trial patients dosed to date | MAIA Biotechnology
thio target profile | MAIA Biotechnology
favorable safety profile | MAIA Biotechnology
by line of therapy | MAIA Biotechnology
disease control men | MAIA Biotechnology
by dose level a of | MAIA Biotechnology
swimmer plot all subjects by start date | MAIA Biotechnology
swimmer plot second line | MAIA Biotechnology
swimmer plot lines and | MAIA Biotechnology
dysfunction induced foci confocal microscopy image of cell nucleus after treatment with thio in cell by of thio | MAIA Biotechnology
thio trial planned to expand best combination arms | MAIA Biotechnology
thio trial rationale | MAIA Biotechnology
thio | MAIA Biotechnology
thio | MAIA Biotechnology
thio | MAIA Biotechnology
orphan drug designation | MAIA Biotechnology
excellent efficacy in models | MAIA Biotechnology
anti cancer immune memory | MAIA Biotechnology
thio trial planned a | MAIA Biotechnology
exclusivity and intellectual property goal new chemical entity marketing | MAIA Biotechnology
experienced management team a cure | MAIA Biotechnology
capitalization table cash balance | MAIA Biotechnology
investment opportunity | MAIA Biotechnology
significant market opportunity group | MAIA Biotechnology
comparable companies i mala turning point | MAIA Biotechnology
multiple value driving milestones thio thio thio | MAIA Biotechnology
listed maw a | MAIA Biotechnology
See More
MAIA Biotechnology
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Cancer
Tumor
Recent decks by MAIA Biotechnology
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Presentation
July 2023
See all presentations by MAIA Biotechnology (4 decks)
Related decks
BioAtla
IPO
December 2020
Genprex
Investor Presentation
October 2022
BioNTech
Results
November 2020
RenovoRx
IPO
August 2021
Genelux
Investor Presentation
December 2023
Fusion Pharmaceuticals
Investor Presentation
January 2024
Genelux
Investor Presentation
February 2024
Enochian Biosciences
Investor Presentation
January 2024
Recent decks by MAIA Biotechnology
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Presentation
July 2023
BioAtla
IPO
December 2020
Genprex
Investor Presentation
October 2022
BioNTech
Results
November 2020
RenovoRx
IPO
August 2021
Genelux
Investor Presentation
December 2023
Fusion Pharmaceuticals
Investor Presentation
January 2024
Genelux
Investor Presentation
February 2024
Enochian Biosciences
Investor Presentation
January 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io